Cancer News

Science Daily
Posted 3 months ago
Less breast cancer radiation has better cosmetic outcomes, say 65+ patients

When breast cancer patients 65 or older were asked, they reported being more satisfied with the cosmetic outcomes of less radiation, in the long term. However, this should be balanced with a slightly higher recurrence risk.

Read full article
MedPage Today
Posted 3 months ago
Combination treatment for HR positive, HER2 positive breast cancer improves outcomes

Adding pertuzumab to a standard regimen for hormone receptor-positive, HER2-positive, locally advanced or metastatic breast cancer improved progression-free survival. These were the recently announced results of a clinical trial.

Read full article
Reuters
Posted 3 months ago
A system to cool the scalp may help prevent hair loss for breast cancer patients

Women diagnosed with stage 1 or 2 breast cancer used a scalp-cooling system while undergoing chemotherapy, in a clinical trial. The results show that it helped them prevent hair loss. 

Read full article
eCancer News
Posted 3 months ago
Improved response to treatment against breast cancer with BRCA mutation

Adding veliparib to carboplatin and paclitaxel chemotherapy improved the overall response rate among patients with locally recurrent or metastatic breast cancer with BRCA1 or BRCA2 mutations. This was achieved without increasing side-effects. 

Read full article
eCancer News
Posted 4 months ago
Combining breast cancer treatments more than double progression free survival

Adding everolimus to fulvestrant more than doubled progression-free survival for women with metastatic hormone receptor (HR)-positive, HER2-negative breast cancer resistant to aromatase inhibitor therapy.

Read full article
MedPage Today
Posted 5 months ago
Combination therapy for metastatic breast cancer shows improved survival

Progression-free survival doubled in some patients with metastatic breast cancer treated with everolimus plus fulvestrant, compared with fulvestrant alone. These are results from a randomized trial.

Read full article
eCancer News
Posted 5 months ago
Radiation therapy before breast reconstruction may affect quality of life

Many breast cancer patients will consider breast reconstruction after mastectomy. Radiation therapy can alter the tissue around the breast, reportedly increasing women’s concerns.

Read full article
eCancer News
Posted 5 months ago
Combination therapy against HR-positive, HER2-negative advanced breast cancer

A clinical trial focused on patients with HR-positive, HER2-negative, locally advanced or metastatic breast cancer. Combining buparlisib with fulvestrant improved outcomes, but researchers feel more studies are needed.

Read full article
eCancer News
Posted 5 months ago
FDA approves another use of bevacizumab for treating ovarian cancer

The U.S. FDA has approved bevacizumab for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The approval indicates combination with other agents.

Read full article
eCancer News
Posted 5 months ago
Some leukemia patients may be able to safely stop their treatment

New research shows some patients with chronic myeloid leukemia can stop their treatment once in remission. What's more, they may even benefit from doing so.

Read full article
Science Daily
Posted 5 months ago
Could weight loss help reduce risk of breast cancer recurrence?

Emerging research seems to indicate that women who had breast cancer and maintain a normal weight have lower risk of the cancer coming back.

Read full article
Science Daily
Posted 5 months ago
New combination therapy for breast cancer one step closer to approval

Adding palbociclib to letrozole for the treatment of estrogen receptor positive (ER+), HER2-negative (HER2-) advanced breast cancer showed substantial benefit.

Read full article
Reuters
Posted 6 months ago
Women with history of depression may have worse outcomes in breast cancer

Women who have a history of depression may have worse survival outcomes, compared to patients without past mental health challenges. 

Read full article
eCancer News
Posted 6 months ago
New breast cancer drug approved by the European Commission

Palbociclib is now approved in Europe for the treatment of women with hormone receptor-positive, HER2-negative (HR+/HER2-), locally advanced or metastatic breast cancer.

Read full article
Reuters
Posted 6 months ago
Higher vitamin D levels may be linked to better breast cancer outcomes

Breast cancer patients with high vitamin D levels in the blood may have less dangerous tumors and better outcomes. This is according to research within an ongoing study.

Read full article
eCancer News
Posted 6 months ago
Benefits of breast reconstruction after mastectomy do not change much with age

Older women enjoy the same benefits from breast reconstruction following mastectomy for breast cancer as younger women. This is according to a recently published comprehensive study.

Read full article
eCancer News
Posted 6 months ago
Pembrolizumab: A new treatment option for metastatic lung cancer

Pembrolizumab has been approved by the FDA, for the first-line treatment of patients with metastatic non-small cell lung cancer. 

Read full article
Science Daily
Posted 6 months ago
Precision medicine contributes in chemotherapy decisions

Precision medicine in cancer care can help patients and doctors decide when chemotherapy is needed. For that reason, risk of recurrence and stage disease should be assessed. 

Read full article
eCancer News
Posted 6 months ago
Short-term training improves aerobic performance in lung cancer

High-intensity exercise training before surgery appears to improve aerobic performance in non-small cell lung cancer patients but it does not reduce the complications after tumor resection.

Read full article
Medical News Today
Posted 6 months ago
Childhood cancer survivors lack a balanced diet

A new study indicated that childhood cancer survivors have, very often, a poor diet during their adult life. This may increase the risk of chronic diseases, as cancer survivors are more prone to developing illnesses.

Read full article